Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $341.64 | $19.04 | 1,694.77% | 6,832.80x | 100.85x | 7.57x | 9.16x | 6.60x | $529.27M | 1.41% | $4.13B | 37.48 | $35.71B | 112.29 | ||
| NVO | NOVO NORDISK A S | $59.32 | $146.40 | -59.48% | 16.50x | 2.60x | 5.42x | 10.07x | 0.17x | $9.34B | 3.54% | $26.18B | 5.89 | $274.24B | 11.05 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $365.46 | $36.46 | 902.45% | 1,178.90x | 51.03x | 14.96x | 206.43x | 3.81x | $221.36M | 0.46% | $233.89M | 1.78 | $50.01B | 329.15 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $41.83 | $17.03 | 145.60% | 85.37x | 24.48x | 5.23x | 5.92x | 1.06x | $101.73M | 3.26% | $535.38M | 7.17 | $3.01B | 56.09 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $9.03 | $16.22 | -44.34% | 18.81x | 15.88x | 5.99x | 3.82x | 0.24x | -$23.64M | -4.68% | $133.17M | 2.38 | $516.64M | 7.69 | ||
| CORT | CORCEPT THERAPEUTICS INC | $36.31 | $40.96 | -11.35% | 36.31x | 72.36x | 5.07x | 6.04x | 0.37x | $162.57M | 4.32% | $631.90M | 6.10 | $3.70B | 56.09 | ||
| VCEL | VERICEL CORP | $37.72 | $9.42 | 300.24% | 145.08x | 64.88x | 7.36x | 5.93x | 1.72x | $20.38M | 1.07% | $321.86M | 6.38 | $1.91B | 65.00 | ||
| ARGX | ARGENX SE | $816.37 | $365.51 | 123.35% | 32.62x | 27.23x | 26,334.52x | 6.95x | 1.32x | $467.72M | 0.94% | $7.17B | 117.50 | $47.42B | 58.45 | ||
| ADMA | ADMA BIOLOGICS INC | $17.36 | $12.58 | 38.00% | 19.73x | 19.02x | 8.48x | 9.58x | 0.83x | $40.73M | 0.99% | $431.19M | 1.81 | $4.14B | 24.07 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.31 | $18.87 | -71.87% | 3.34x | -98.52x | 758.57x | 1.68x | 0.20x | -$82.36M | -28.59% | $171.23M | 3.16 | $228.64M | 2.54 | ||
| TECH | BIO-TECHNE CORP | $71.38 | $16.02 | 345.44% | 142.75x | 35.34x | 9.12x | 5.66x | 1.96x | $224.06M | 2.02% | $1.97B | 12.65 | $11.37B | 51.47 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $199.51 | $71.39 | 179.47% | 86.37x | 23.58x | 15.55x | 4.13x | 1.24x | $30.76M | 0.79% | $950.17M | 48.53 | $4.24B | 41.14 | ||
| KRYS | KRYSTAL BIOTECH INC | $286.00 | $114.33 | 150.14% | 41.45x | 35.29x | 22.19x | 7.29x | 1.38x | $166.02M | 2.00% | $1.14B | 39.30 | $7.91B | 40.92 | ||
| GMAB | GENMAB A | $32.95 | $126.27 | -73.91% | 14.06x | 1.95x | 5.94x | 3.68x | 0.11x | $1.19B | 5.64% | $5.75B | 8.96 | $19.54B | 9.76 | ||
| RPRX | ROYALTY PHARMA PLC | $39.72 | $46.65 | -14.85% | 22.57x | 7.66x | 7.30x | 2.38x | 0.39x | $2.11B | 12.31% | $9.62B | 22.28 | $30.93B | 29.62 | ||
| XOMA | XOMA ROYALTY CORP | $27.27 | $15.65 | 74.24% | 33.67x | 86.74x | 7.03x | 3.84x | 0.89x | -$12.41M | -3.75% | $87.94M | 7.25 | $379.12M | 14.17 | ||
| VCYT | VERACYTE INC | $43.30 | $12.48 | 247.02% | 111.03x | 40.47x | 6.89x | 2.72x | 1.53x | $98.21M | 2.88% | $1.26B | 15.98 | $3.15B | 55.20 | ||
| MNKD | MANNKIND CORP | $5.71 | $2.88 | 98.00% | 57.10x | 46.65x | 5.58x | -39.36x | 0.89x | $43.39M | 2.47% | -$44.55M | -0.15 | $1.99B | 27.13 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.20 | $4.27 | 45.21% | 22.96x | 20.60x | 3.97x | 7.00x | 0.82x | $21.15M | 4.27% | $70.68M | 0.89 | $433.56M | 19.11 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $14.78 | $9.73 | 51.97% | 25.48x | 15.50x | 7.33x | 5.33x | 0.83x | $119.87M | 6.15% | $365.77M | 2.78 | $1.95B | 18.87 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.69 | $60.50 | -39.36% | 11.36x | 8.68x | 2.56x | 2.53x | 0.32x | $296.89M | 14.06% | $835.12M | 14.51 | $1.63B | 6.06 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $461.14 | $187.91 | 145.40% | 32.23x | 22.65x | 10.05x | 6.76x | 1.57x | $3.34B | 2.83% | $17.32B | 67.76 | $113.90B | 24.43 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.07 | $3.53 | -41.35% | 29.57x | 11.71x | 2.65x | 3.15x | 0.24x | -$11.69M | -7.10% | $52.91M | 0.67 | $161.00M | 18.15 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.13 | $23.14 | 4.28% | 13.48x | 13.11x | 5.12x | 3.22x | 0.67x | $234.54M | 7.93% | $920.25M | 7.51 | $2.28B | 7.03 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $56.77 | $50.54 | 12.34% | 20.87x | 12.22x | 3.52x | 1.80x | 0.59x | $832.13M | 7.63% | $6.06B | 31.54 | $10.25B | 13.27 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $20.95 | $6.42 | 226.49% | 59.86x | -18.48x | 2.61x | 6.61x | 1.71x | $78.64M | 2.97% | $401.17M | 3.17 | $2.65B | 28.33 | ||
| CRMD | CORMEDIX INC | $7.33 | $14.89 | -50.77% | 3.23x | 3.87x | 2.60x | 1.54x | 1.33x | $74.42M | 13.37% | $374.13M | 4.93 | $677.95M | 6.04 | ||
| EXEL | EXELIXIS INC | $44.81 | $36.06 | 24.25% | 18.22x | 13.82x | 5.26x | 5.56x | 0.73x | $779.77M | 6.48% | $2.16B | 8.05 | $11.81B | 12.74 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.71 | $79.98 | -10.34% | 14.66x | 8.58x | 6.76x | 16.73x | 0.50x | $602.40M | 7.17% | $503.92M | 4.30 | $9.52B | 11.26 | ||
| MDXG | MIMEDX GROUP INC | $5.33 | $5.00 | 6.63% | 19.04x | 21.33x | 2.01x | 3.30x | 0.57x | $66.82M | 8.46% | $238.95M | 1.61 | $665.52M | 9.62 | ||
| INVA | INNOVIVA INC | $19.60 | $19.16 | 2.31% | 10.37x | 8.97x | 3.48x | 1.45x | 0.84x | $196.54M | 14.52% | $1.01B | 14.63 | $1.25B | 5.80 | ||
| UTHR | UNITED THERAPEUTICS CORP | $469.77 | $251.97 | 86.44% | 16.49x | 15.94x | 6.58x | 3.07x | 1.88x | $1.12B | 5.45% | $6.59B | 150.46 | $18.89B | 10.65 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $26.76 | $12.13 | 120.66% | 17.04x | 33.16x | 4.31x | 4.94x | 3.01x | $197.81M | 4.38% | $917.27M | 5.43 | $4.30B | 14.96 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $749.33 | $409.50 | 82.99% | 17.25x | 16.21x | 5.45x | 2.54x | 1.67x | $4.22B | 5.44% | $30.96B | 298.82 | $78.95B | 13.82 | ||
| INCY | INCYTE CORP | $104.67 | $75.64 | 38.38% | 17.33x | 13.03x | 4.26x | 4.42x | 0.92x | $1.20B | 5.85% | $4.65B | 23.77 | $18.13B | 10.77 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.